Habib J. Dable - Jan 17, 2024 Form 3 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
Director
Signature
/s/ Charles N. York II, as Attorney-in-Fact
Stock symbol
DAWN
Transactions as of
Jan 17, 2024
Transactions value $
$0
Form type
3
Date filed
1/19/2024, 05:01 PM
Previous filing
Jan 4, 2024
Next filing
Mar 6, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney No securities are beneficially owned.